Hudson Bay Capital Management LP Tyme Technologies, Inc. Transaction History

Hudson Bay Capital Management LP

  • $18.6 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$0.87 - $1.26 $1.7 Million - $2.47 Million
-1,956,632 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$0.93 - $1.35 $226,332 - $328,546
-243,368 Reduced 11.06%
1,956,632 $1.92 Million
Q2 2020

Aug 12, 2020
BUY
$0.97 - $1.7 $2.13 Million - $3.74 Million
2,200,000 New
2,200,000 $2.93 Million
Q3 2019

Nov 13, 2019
SELL
$0.97 - $1.77 $859,407 - $1.57 Million
-885,987 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$0.96 - $1.89 $4.14 Million - $8.16 Million
-4,315,964 Reduced 82.97%
885,987 $1.08 Million
Q1 2019

May 15, 2019
BUY
$1.76 - $3.73 $9.16 Million - $19.4 Million
5,201,951 New
5,201,951 $9.16 Million

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email